Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre

doi:10.2807/1560-7917.ES.2018.23.7.18-00057

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

Primary Health Care Sentinel Network
, Network for Influenza Surveillance in Hospitals of Navarre

Circular Traceability

Navarre Institute for Health Research
Instituto de Salud Pública de Navarra
Instituto de Salud Carlos III
Hospital Reina Sofia
Hospital García Orcoyen

Research output: Contribution to journal › Article › peer-review

30 Citations (Scopus)

Abstract

The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccination only, and 22% for any prior doses, and 43%, 51% and 54%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B.

Original language	English
Article number	18-00057
Journal	Eurosurveillance
Volume	23
Issue number	7
DOIs	https://doi.org/10.2807/1560-7917.ES.2018.23.7.18-00057
Publication status	Published - 15 Feb 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2807/1560-7917.ES.2018.23.7.18-00057

Interim effectiveness of trivalentLicence: Unspecified

Cite this

@article{efc38b64e6dc48e88547c89887c8580b,

title = "Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18",

abstract = "The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39\% (95\% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41\% for current and any prior doses, 67\% for current vaccination only, and 22\% for any prior doses, and 43\%, 51\% and 54\%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B.",

author = "\{Primary Health Care Sentinel Network\} and \{Network for Influenza Surveillance in Hospitals of Navarre\} and Jes{\'u}s Castilla and Ana Navascu{\'e}s and Itziar Casado and Alejandra P{\'e}rez-Garc{\'i}a and Aitziber Aguinaga and Guillermo Ezpeleta and Francisco Pozo and Carmen Ezpeleta and Iv{\'a}n Mart{\'i}nez-Baz and I. Abad and P. Aldaz and R. Ansorena and I. Arc{\'e}iz and E. Arina and Arrechea, \{M. A.\} and I. Arribas and N. Azn{\'a}rez and Bartolom{\'e}, \{F. C.\} and A. Beguiristain and A. Beltr{\'a}n and M. Bidarte and I. Blanco and A. Brugos and B. Cano and Castresana, \{M. V.\} and Cenoz, \{J. C.\} and F. Cia and B. Compains and Corpas, \{J. R.\} and F. Cortes and B. Chur{\'i}o and Cuevas, \{P. C.\} and \{Da Costa\}, \{E. M.\} and D{\'i}ez, \{M. R.\} and Escribano, \{F. J.\} and M. Esparza and Esparza, \{M. J.\} and V. Etayo and \{Fern{\'a}ndez Alfaro\}, C. and B. Flamarique and Garc{\'e}s, \{M. L.\} and \{Garc{\'i}a Alb{\'e}niz\}, T. and \{Garc{\'i}a Nicol{\'a}s\}, \{F. J.\} and Germ{\'a}n, \{A. B.\} and A. Giner and Guiu, \{J. O.\} and Gurbindo, \{J. C.\} and Guruchaga, \{M. J.\} and Heras, \{J. A.\} and \{Hern{\'a}ndez Galindo\}, M.",

year = "2018",

month = feb,

day = "15",

doi = "10.2807/1560-7917.ES.2018.23.7.18-00057",

language = "English",

volume = "23",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "7",

}

TY - JOUR

T1 - Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

AU - Primary Health Care Sentinel Network

AU - Network for Influenza Surveillance in Hospitals of Navarre

AU - Castilla, Jesús

AU - Navascués, Ana

AU - Casado, Itziar

AU - Pérez-García, Alejandra

AU - Aguinaga, Aitziber

AU - Ezpeleta, Guillermo

AU - Pozo, Francisco

AU - Ezpeleta, Carmen

AU - Martínez-Baz, Iván

AU - Abad, I.

AU - Aldaz, P.

AU - Ansorena, R.

AU - Arcéiz, I.

AU - Arina, E.

AU - Arrechea, M. A.

AU - Arribas, I.

AU - Aznárez, N.

AU - Bartolomé, F. C.

AU - Beguiristain, A.

AU - Beltrán, A.

AU - Bidarte, M.

AU - Blanco, I.

AU - Brugos, A.

AU - Cano, B.

AU - Castresana, M. V.

AU - Cenoz, J. C.

AU - Cia, F.

AU - Compains, B.

AU - Corpas, J. R.

AU - Cortes, F.

AU - Churío, B.

AU - Cuevas, P. C.

AU - Da Costa, E. M.

AU - Díez, M. R.

AU - Escribano, F. J.

AU - Esparza, M.

AU - Esparza, M. J.

AU - Etayo, V.

AU - Fernández Alfaro, C.

AU - Flamarique, B.

AU - Garcés, M. L.

AU - García Albéniz, T.

AU - García Nicolás, F. J.

AU - Germán, A. B.

AU - Giner, A.

AU - Guiu, J. O.

AU - Gurbindo, J. C.

AU - Guruchaga, M. J.

AU - Heras, J. A.

AU - Hernández Galindo, M.

PY - 2018/2/15

Y1 - 2018/2/15

N2 - The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccination only, and 22% for any prior doses, and 43%, 51% and 54%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B.

AB - The 2017/18 interim estimate of trivalent influenza vaccine effectiveness (VE) was 39% (95% confidence interval: 20–54) in Navarre. Compared with individuals unvaccinated in the current and five previous seasons, VE against influenza B was 41% for current and any prior doses, 67% for current vaccination only, and 22% for any prior doses, and 43%, 51% and 54%, respectively against influenza A(H3N2). This suggests moderate VE despite predominance of lineage mismatched influenza B.

UR - https://www.scopus.com/pages/publications/85043382214

U2 - 10.2807/1560-7917.ES.2018.23.7.18-00057

DO - 10.2807/1560-7917.ES.2018.23.7.18-00057

M3 - Article

C2 - 29471624

AN - SCOPUS:85043382214

SN - 1025-496X

VL - 23

JO - Eurosurveillance

JF - Eurosurveillance

IS - 7

M1 - 18-00057

ER -

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this